nodes	percent_of_prediction	percent_of_DWPC	metapath
Sucralfate—EGF—corneal epithelium—ocular cancer	0.133	0.431	CbGeAlD
Sucralfate—EGF—cornea—ocular cancer	0.0965	0.314	CbGeAlD
Sucralfate—Venous thrombosis—Carboplatin—ocular cancer	0.0639	0.258	CcSEcCtD
Sucralfate—Fluid overload—Carboplatin—ocular cancer	0.0554	0.224	CcSEcCtD
Sucralfate—Extravasation—Carboplatin—ocular cancer	0.0395	0.159	CcSEcCtD
Sucralfate—Phlebitis—Carboplatin—ocular cancer	0.029	0.117	CcSEcCtD
Sucralfate—Extravasation—Dactinomycin—ocular cancer	0.0147	0.0592	CcSEcCtD
Sucralfate—FGB—lymphoid tissue—ocular cancer	0.0134	0.0436	CbGeAlD
Sucralfate—Infection—Carboplatin—ocular cancer	0.0122	0.0493	CcSEcCtD
Sucralfate—EGF—eye—ocular cancer	0.0119	0.0387	CbGeAlD
Sucralfate—EGF—retina—ocular cancer	0.0118	0.0383	CbGeAlD
Sucralfate—FGA—lymphoid tissue—ocular cancer	0.0115	0.0373	CbGeAlD
Sucralfate—EGF—epithelium—ocular cancer	0.0109	0.0354	CbGeAlD
Sucralfate—Phlebitis—Dactinomycin—ocular cancer	0.0108	0.0435	CcSEcCtD
Sucralfate—FGF2—eye—ocular cancer	0.0105	0.0341	CbGeAlD
Sucralfate—Body temperature increased—Carboplatin—ocular cancer	0.00972	0.0392	CcSEcCtD
Sucralfate—EGF—lymphoid tissue—ocular cancer	0.00838	0.0273	CbGeAlD
Sucralfate—Oedema—Dactinomycin—ocular cancer	0.00457	0.0184	CcSEcCtD
Sucralfate—Infection—Dactinomycin—ocular cancer	0.00454	0.0183	CcSEcCtD
Sucralfate—Body temperature increased—Dactinomycin—ocular cancer	0.00361	0.0146	CcSEcCtD
Sucralfate—FGF2—B Cell Activation—CDKN1A—ocular cancer	0.000368	0.000827	CbGpPWpGaD
Sucralfate—FGF2—PI-3K cascade—AKT1—ocular cancer	0.000367	0.000825	CbGpPWpGaD
Sucralfate—FGB—Hemostasis—TGFB1—ocular cancer	0.000367	0.000825	CbGpPWpGaD
Sucralfate—FGF2—Signaling by Insulin receptor—HRAS—ocular cancer	0.000363	0.000816	CbGpPWpGaD
Sucralfate—EGF—NGF signalling via TRKA from the plasma membrane—HRAS—ocular cancer	0.000362	0.000815	CbGpPWpGaD
Sucralfate—EGF—Fc epsilon receptor (FCERI) signaling—AKT1—ocular cancer	0.000361	0.000812	CbGpPWpGaD
Sucralfate—EGF—DAP12 interactions—AKT1—ocular cancer	0.000361	0.000812	CbGpPWpGaD
Sucralfate—EGF—Signaling by FGFR in disease—AKT1—ocular cancer	0.000361	0.000812	CbGpPWpGaD
Sucralfate—FGA—Hemostasis—TGFB1—ocular cancer	0.000359	0.000808	CbGpPWpGaD
Sucralfate—FGG—Hemostasis—TGFB1—ocular cancer	0.000359	0.000808	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—HDAC1—ocular cancer	0.000359	0.000807	CbGpPWpGaD
Sucralfate—FGF2—PI3K/AKT activation—AKT1—ocular cancer	0.000358	0.000805	CbGpPWpGaD
Sucralfate—EGF—Signaling by EGFR—AKT1—ocular cancer	0.000358	0.000805	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.000356	0.0008	CbGpPWpGaD
Sucralfate—FGF2—GAB1 signalosome—AKT1—ocular cancer	0.000355	0.000799	CbGpPWpGaD
Sucralfate—EGF—Signaling by EGFR in Cancer—AKT1—ocular cancer	0.000355	0.000798	CbGpPWpGaD
Sucralfate—EGF—Signaling by PDGF—AKT1—ocular cancer	0.000353	0.000794	CbGpPWpGaD
Sucralfate—FGF2—NGF signalling via TRKA from the plasma membrane—CDKN1A—ocular cancer	0.000352	0.000792	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—HDAC1—ocular cancer	0.000351	0.00079	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—HDAC1—ocular cancer	0.000351	0.00079	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—SAG—ocular cancer	0.000349	0.000784	CbGpPWpGaD
Sucralfate—FGF2—Role of LAT2/NTAL/LAB on calcium mobilization—AKT1—ocular cancer	0.000347	0.000781	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—GNA11—ocular cancer	0.000346	0.000777	CbGpPWpGaD
Sucralfate—FGF2—Disease—TFDP1—ocular cancer	0.000341	0.000768	CbGpPWpGaD
Sucralfate—EGF—Focal Adhesion—AKT1—ocular cancer	0.000341	0.000767	CbGpPWpGaD
Sucralfate—EGF—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.00034	0.000764	CbGpPWpGaD
Sucralfate—EGF—B Cell Activation—AKT1—ocular cancer	0.000334	0.000752	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—CDKN2B—ocular cancer	0.000322	0.000723	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—MDM2—ocular cancer	0.000321	0.000723	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—GNAQ—ocular cancer	0.000321	0.000723	CbGpPWpGaD
Sucralfate—EGF—NGF signalling via TRKA from the plasma membrane—AKT1—ocular cancer	0.00032	0.000719	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—CDKN2B—ocular cancer	0.000315	0.000709	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—CDKN2B—ocular cancer	0.000315	0.000709	CbGpPWpGaD
Sucralfate—EGF—Disease—HDAC1—ocular cancer	0.000313	0.000704	CbGpPWpGaD
Sucralfate—FGF2—Signaling by SCF-KIT—HRAS—ocular cancer	0.00031	0.000698	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.00031	0.000697	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.000309	0.000696	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—E2F5—ocular cancer	0.000309	0.000694	CbGpPWpGaD
Sucralfate—EGF—Platelet activation, signaling and aggregation—AKT1—ocular cancer	0.000302	0.00068	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—E2F4—ocular cancer	0.000302	0.00068	CbGpPWpGaD
Sucralfate—FGB—Hemostasis—TP53—ocular cancer	0.000302	0.000679	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—MAML2—ocular cancer	0.0003	0.000675	CbGpPWpGaD
Sucralfate—FGF2—Downstream signaling of activated FGFR—HRAS—ocular cancer	0.000297	0.000668	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—RBL1—ocular cancer	0.000296	0.000667	CbGpPWpGaD
Sucralfate—FGA—Hemostasis—TP53—ocular cancer	0.000296	0.000665	CbGpPWpGaD
Sucralfate—FGG—Hemostasis—TP53—ocular cancer	0.000296	0.000665	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—E2F1—ocular cancer	0.000295	0.000664	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—CDKN1B—ocular cancer	0.000293	0.00066	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB4—HRAS—ocular cancer	0.000292	0.000658	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—MDM2—ocular cancer	0.00029	0.000651	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—E2F1—ocular cancer	0.000289	0.00065	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—E2F1—ocular cancer	0.000289	0.00065	CbGpPWpGaD
Sucralfate—FGB—Hemostasis—HRAS—ocular cancer	0.000289	0.000649	CbGpPWpGaD
Sucralfate—FGA—Hemostasis—HRAS—ocular cancer	0.000283	0.000636	CbGpPWpGaD
Sucralfate—FGG—Hemostasis—HRAS—ocular cancer	0.000283	0.000636	CbGpPWpGaD
Sucralfate—EGF—Disease—CDKN2B—ocular cancer	0.000281	0.000631	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—CDK4—ocular cancer	0.00028	0.00063	CbGpPWpGaD
Sucralfate—FGF2—Downstream signal transduction—HRAS—ocular cancer	0.000279	0.000628	CbGpPWpGaD
Sucralfate—EGF—Signaling by NGF—HRAS—ocular cancer	0.000279	0.000627	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—MDM2—ocular cancer	0.000278	0.000625	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR—HRAS—ocular cancer	0.000278	0.000625	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB2—HRAS—ocular cancer	0.000276	0.000622	CbGpPWpGaD
Sucralfate—FGF2—DAP12 signaling—HRAS—ocular cancer	0.000275	0.000619	CbGpPWpGaD
Sucralfate—FGF2—Signaling by SCF-KIT—AKT1—ocular cancer	0.000274	0.000617	CbGpPWpGaD
Sucralfate—FGF2—Downstream signaling events of B Cell Receptor (BCR)—HRAS—ocular cancer	0.000271	0.00061	CbGpPWpGaD
Sucralfate—FGF2—Disease—MAML2—ocular cancer	0.000271	0.00061	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—CDKN1A—ocular cancer	0.000271	0.000609	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—CDKN1B—ocular cancer	0.000264	0.000595	CbGpPWpGaD
Sucralfate—FGF2—Downstream signaling of activated FGFR—AKT1—ocular cancer	0.000262	0.00059	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—GNA11—ocular cancer	0.000262	0.000589	CbGpPWpGaD
Sucralfate—FGF2—DAP12 interactions—HRAS—ocular cancer	0.000259	0.000582	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR in disease—HRAS—ocular cancer	0.000259	0.000582	CbGpPWpGaD
Sucralfate—FGF2—Fc epsilon receptor (FCERI) signaling—HRAS—ocular cancer	0.000259	0.000582	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB4—AKT1—ocular cancer	0.000258	0.000581	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—EP300—ocular cancer	0.000258	0.00058	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—E2F3—ocular cancer	0.000257	0.000578	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR—HRAS—ocular cancer	0.000256	0.000577	CbGpPWpGaD
Sucralfate—FGB—Hemostasis—AKT1—ocular cancer	0.000255	0.000573	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.000255	0.000573	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR in Cancer—HRAS—ocular cancer	0.000254	0.000572	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—CDKN1B—ocular cancer	0.000254	0.000571	CbGpPWpGaD
Sucralfate—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—ocular cancer	0.000254	0.000571	CbGpPWpGaD
Sucralfate—FGF2—Signaling by PDGF—HRAS—ocular cancer	0.000253	0.000569	CbGpPWpGaD
Sucralfate—FGG—Hemostasis—AKT1—ocular cancer	0.00025	0.000562	CbGpPWpGaD
Sucralfate—FGA—Hemostasis—AKT1—ocular cancer	0.00025	0.000562	CbGpPWpGaD
Sucralfate—FGA—Disease—MDM2—ocular cancer	0.000249	0.000561	CbGpPWpGaD
Sucralfate—FGF2—Downstream signal transduction—AKT1—ocular cancer	0.000247	0.000555	CbGpPWpGaD
Sucralfate—EGF—Signaling by NGF—AKT1—ocular cancer	0.000246	0.000553	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR—AKT1—ocular cancer	0.000245	0.000552	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB2—AKT1—ocular cancer	0.000244	0.000549	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—CDKN1A—ocular cancer	0.000244	0.000549	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—GNAQ—ocular cancer	0.000243	0.000547	CbGpPWpGaD
Sucralfate—FGF2—DAP12 signaling—AKT1—ocular cancer	0.000243	0.000546	CbGpPWpGaD
Sucralfate—FGF2—B Cell Activation—HRAS—ocular cancer	0.00024	0.000539	CbGpPWpGaD
Sucralfate—FGF2—Downstream signaling events of B Cell Receptor (BCR)—AKT1—ocular cancer	0.000239	0.000539	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—TFDP1—ocular cancer	0.000239	0.000537	CbGpPWpGaD
Sucralfate—FGF2—Extracellular matrix organization—TGFB1—ocular cancer	0.000239	0.000537	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—CDKN1A—ocular cancer	0.000234	0.000527	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—EP300—ocular cancer	0.000232	0.000522	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PSPH—ocular cancer	0.000229	0.000516	CbGpPWpGaD
Sucralfate—FGF2—NGF signalling via TRKA from the plasma membrane—HRAS—ocular cancer	0.000229	0.000516	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR in disease—AKT1—ocular cancer	0.000229	0.000514	CbGpPWpGaD
Sucralfate—FGF2—Fc epsilon receptor (FCERI) signaling—AKT1—ocular cancer	0.000229	0.000514	CbGpPWpGaD
Sucralfate—FGF2—DAP12 interactions—AKT1—ocular cancer	0.000229	0.000514	CbGpPWpGaD
Sucralfate—FGA—Disease—CDKN1B—ocular cancer	0.000228	0.000512	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR—AKT1—ocular cancer	0.000226	0.000509	CbGpPWpGaD
Sucralfate—ALB—Platelet degranulation—TGFB1—ocular cancer	0.000226	0.000509	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR in Cancer—AKT1—ocular cancer	0.000224	0.000505	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—TGFB1—ocular cancer	0.000224	0.000504	CbGpPWpGaD
Sucralfate—FGF2—Signaling by PDGF—AKT1—ocular cancer	0.000223	0.000503	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—HDAC1—ocular cancer	0.000219	0.000493	CbGpPWpGaD
Sucralfate—ALB—Folate Metabolism—TP53—ocular cancer	0.000217	0.000489	CbGpPWpGaD
Sucralfate—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—ocular cancer	0.000216	0.000485	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.000215	0.000484	CbGpPWpGaD
Sucralfate—FGF2—B Cell Activation—AKT1—ocular cancer	0.000211	0.000476	CbGpPWpGaD
Sucralfate—FGA—Disease—CDKN1A—ocular cancer	0.00021	0.000473	CbGpPWpGaD
Sucralfate—FGF2—NGF signalling via TRKA from the plasma membrane—AKT1—ocular cancer	0.000202	0.000455	CbGpPWpGaD
Sucralfate—FGA—Disease—EP300—ocular cancer	0.0002	0.00045	CbGpPWpGaD
Sucralfate—FGF2—Disease—HDAC1—ocular cancer	0.000198	0.000446	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CDKN2B—ocular cancer	0.000197	0.000442	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—MAML2—ocular cancer	0.00019	0.000427	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—TP53—ocular cancer	0.000185	0.000415	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—MDM2—ocular cancer	0.000183	0.000412	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—E2F1—ocular cancer	0.00018	0.000406	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—MDM2—ocular cancer	0.000178	0.000401	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—GNA11—ocular cancer	0.000178	0.000401	CbGpPWpGaD
Sucralfate—FGF2—Disease—CDKN2B—ocular cancer	0.000178	0.0004	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—HRAS—ocular cancer	0.000176	0.000397	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—HRAS—ocular cancer	0.000176	0.000397	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—MDM2—ocular cancer	0.000176	0.000396	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—MDM2—ocular cancer	0.000175	0.000393	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—MDM2—ocular cancer	0.000175	0.000393	CbGpPWpGaD
Sucralfate—FGA—Disease—MYC—ocular cancer	0.000174	0.000392	CbGpPWpGaD
Sucralfate—FGA—Disease—TGFB1—ocular cancer	0.000174	0.000391	CbGpPWpGaD
Sucralfate—EGF—Immune System—MDM2—ocular cancer	0.000169	0.000379	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—CDKN1B—ocular cancer	0.000167	0.000376	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—EP300—ocular cancer	0.000166	0.000374	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—GNA11—ocular cancer	0.000166	0.000373	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—GNAQ—ocular cancer	0.000166	0.000373	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—CDKN1B—ocular cancer	0.000163	0.000366	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—CDKN1B—ocular cancer	0.000161	0.000361	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—CDKN1B—ocular cancer	0.00016	0.000359	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—CDKN1B—ocular cancer	0.00016	0.000359	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—HRAS—ocular cancer	0.000159	0.000357	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—AKT1—ocular cancer	0.000156	0.000351	CbGpPWpGaD
Sucralfate—EGF—Disease—MDM2—ocular cancer	0.000156	0.00035	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—AKT1—ocular cancer	0.000156	0.00035	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—CCND1—ocular cancer	0.000155	0.000349	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—CDKN1A—ocular cancer	0.000154	0.000347	CbGpPWpGaD
Sucralfate—EGF—Immune System—CDKN1B—ocular cancer	0.000154	0.000346	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—GNAQ—ocular cancer	0.000154	0.000346	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—HRAS—ocular cancer	0.000153	0.000343	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—CCND1—ocular cancer	0.000152	0.000342	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—CCND1—ocular cancer	0.000152	0.000342	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—CDKN1A—ocular cancer	0.00015	0.000338	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—HDAC1—ocular cancer	0.000149	0.000336	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—CDKN1A—ocular cancer	0.000148	0.000334	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—CDKN1A—ocular cancer	0.000147	0.000331	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—CDKN1A—ocular cancer	0.000147	0.000331	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—EP300—ocular cancer	0.000147	0.000331	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—TGFB1—ocular cancer	0.000145	0.000325	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—EP300—ocular cancer	0.000143	0.000322	CbGpPWpGaD
Sucralfate—EGF—Disease—CDKN1B—ocular cancer	0.000142	0.00032	CbGpPWpGaD
Sucralfate—EGF—Immune System—CDKN1A—ocular cancer	0.000142	0.00032	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—AKT1—ocular cancer	0.00014	0.000316	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—EP300—ocular cancer	0.00014	0.000315	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—EP300—ocular cancer	0.00014	0.000315	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—HDAC1—ocular cancer	0.000139	0.000312	CbGpPWpGaD
Sucralfate—FGA—Disease—HRAS—ocular cancer	0.000137	0.000308	CbGpPWpGaD
Sucralfate—EGF—Immune System—EP300—ocular cancer	0.000135	0.000304	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—AKT1—ocular cancer	0.000135	0.000303	CbGpPWpGaD
Sucralfate—EGF—Disease—CDKN1A—ocular cancer	0.000131	0.000295	CbGpPWpGaD
Sucralfate—EGF—Disease—EP300—ocular cancer	0.000125	0.000281	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—MYC—ocular cancer	0.000125	0.00028	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CDKN2B—ocular cancer	0.000124	0.00028	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—TGFB1—ocular cancer	0.000124	0.00028	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—MYC—ocular cancer	0.000122	0.000275	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—MYC—ocular cancer	0.000122	0.000275	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—TGFB1—ocular cancer	0.000122	0.000274	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—TGFB1—ocular cancer	0.000122	0.000274	CbGpPWpGaD
Sucralfate—FGA—Disease—AKT1—ocular cancer	0.000121	0.000272	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—E2F1—ocular cancer	0.000114	0.000257	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—HRAS—ocular cancer	0.000114	0.000256	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—MDM2—ocular cancer	0.000109	0.000245	CbGpPWpGaD
Sucralfate—EGF—Disease—MYC—ocular cancer	0.000109	0.000245	CbGpPWpGaD
Sucralfate—EGF—Disease—TGFB1—ocular cancer	0.000109	0.000244	CbGpPWpGaD
Sucralfate—FGF2—Immune System—MDM2—ocular cancer	0.000107	0.00024	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—CDK2—ocular cancer	0.000106	0.000238	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—TP53—ocular cancer	0.000102	0.00023	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—HRAS—ocular cancer	0.000101	0.000226	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—AKT1—ocular cancer	0.000101	0.000226	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—TGFB1—ocular cancer	0.0001	0.000226	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—TP53—ocular cancer	0.0001	0.000226	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—TP53—ocular cancer	0.0001	0.000226	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CDKN1B—ocular cancer	9.96e-05	0.000224	CbGpPWpGaD
Sucralfate—FGF2—Disease—MDM2—ocular cancer	9.85e-05	0.000222	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—HRAS—ocular cancer	9.79e-05	0.00022	CbGpPWpGaD
Sucralfate—FGF2—Immune System—CDKN1B—ocular cancer	9.75e-05	0.000219	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—HRAS—ocular cancer	9.66e-05	0.000217	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—HRAS—ocular cancer	9.59e-05	0.000216	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—HRAS—ocular cancer	9.59e-05	0.000216	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CCND1—ocular cancer	9.5e-05	0.000214	CbGpPWpGaD
Sucralfate—EGF—Immune System—HRAS—ocular cancer	9.25e-05	0.000208	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CDKN1A—ocular cancer	9.19e-05	0.000207	CbGpPWpGaD
Sucralfate—FGF2—Disease—CDKN1B—ocular cancer	9e-05	0.000202	CbGpPWpGaD
Sucralfate—FGF2—Immune System—CDKN1A—ocular cancer	8.99e-05	0.000202	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—AKT1—ocular cancer	8.88e-05	0.0002	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—EP300—ocular cancer	8.74e-05	0.000197	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—AKT1—ocular cancer	8.64e-05	0.000194	CbGpPWpGaD
Sucralfate—FGF2—Immune System—EP300—ocular cancer	8.56e-05	0.000193	CbGpPWpGaD
Sucralfate—EGF—Disease—HRAS—ocular cancer	8.54e-05	0.000192	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—AKT1—ocular cancer	8.53e-05	0.000192	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—AKT1—ocular cancer	8.47e-05	0.00019	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—AKT1—ocular cancer	8.47e-05	0.00019	CbGpPWpGaD
Sucralfate—FGF2—Disease—CDKN1A—ocular cancer	8.3e-05	0.000187	CbGpPWpGaD
Sucralfate—EGF—Immune System—AKT1—ocular cancer	8.17e-05	0.000184	CbGpPWpGaD
Sucralfate—FGF2—Disease—EP300—ocular cancer	7.9e-05	0.000178	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—MYC—ocular cancer	7.62e-05	0.000171	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—TGFB1—ocular cancer	7.6e-05	0.000171	CbGpPWpGaD
Sucralfate—EGF—Disease—AKT1—ocular cancer	7.54e-05	0.00017	CbGpPWpGaD
Sucralfate—ALB—Metabolism—GNA11—ocular cancer	7.22e-05	0.000162	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—AKT1—ocular cancer	6.98e-05	0.000157	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—MDM2—ocular cancer	6.9e-05	0.000155	CbGpPWpGaD
Sucralfate—FGF2—Disease—MYC—ocular cancer	6.88e-05	0.000155	CbGpPWpGaD
Sucralfate—FGF2—Disease—TGFB1—ocular cancer	6.87e-05	0.000155	CbGpPWpGaD
Sucralfate—ALB—Metabolism—GNAQ—ocular cancer	6.71e-05	0.000151	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CDKN1B—ocular cancer	6.3e-05	0.000142	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—TP53—ocular cancer	6.26e-05	0.000141	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CCND1—ocular cancer	6.01e-05	0.000135	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—HRAS—ocular cancer	5.98e-05	0.000135	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—EP300—ocular cancer	5.95e-05	0.000134	CbGpPWpGaD
Sucralfate—FGF2—Immune System—HRAS—ocular cancer	5.86e-05	0.000132	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CDKN1A—ocular cancer	5.81e-05	0.000131	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—EP300—ocular cancer	5.53e-05	0.000124	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—EP300—ocular cancer	5.42e-05	0.000122	CbGpPWpGaD
Sucralfate—FGF2—Disease—HRAS—ocular cancer	5.41e-05	0.000122	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—AKT1—ocular cancer	5.28e-05	0.000119	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—TGFB1—ocular cancer	5.17e-05	0.000116	CbGpPWpGaD
Sucralfate—FGF2—Immune System—AKT1—ocular cancer	5.17e-05	0.000116	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—MYC—ocular cancer	4.82e-05	0.000108	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—TGFB1—ocular cancer	4.81e-05	0.000108	CbGpPWpGaD
Sucralfate—FGF2—Disease—AKT1—ocular cancer	4.77e-05	0.000107	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—TP53—ocular cancer	4.26e-05	9.58e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—HRAS—ocular cancer	4.07e-05	9.16e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—TP53—ocular cancer	3.96e-05	8.91e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—HRAS—ocular cancer	3.79e-05	8.52e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—AKT1—ocular cancer	3.6e-05	8.09e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—AKT1—ocular cancer	3.34e-05	7.52e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—EP300—ocular cancer	2.41e-05	5.43e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—AKT1—ocular cancer	1.46e-05	3.28e-05	CbGpPWpGaD
